Announcements Trials
Browse Landscape

Status

No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 153Observational 14Expanded_access 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Urogenital Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1Genital Neoplasms, Male 1Genital Diseases, Male 1

Interventions

gallium 68 PSMA-11 4Magnetic Resonance Spectroscopy 4carbon-11 acetate 2Abiraterone Acetate 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2zenocutuzumab 1tempol 1talazoparib 1radium Ra 223 dichloride 1pegilodecakin 1motexafin gadolinium 1bicalutamide 1balstilimab 1apalutamide 1TEMPOL-H 1Suspensions 1Standard of Care 1Sodium Acetate 1Proton Pump Inhibitors 1Prednisone 1Prednisolone 1Powders 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid 1MLN 8237 1Hydrocortisone 1Gadolinium 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Prostatic Neoplasms × Abiraterone Acetate × Clear all
NCT01834209 2018-11-07

A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Janssen Research & Development, LLC

No longer available
Genitourinary

Prostatic Neoplasms

NCT01217697 2017-03-24

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Approved for marketing
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡